HS4 subsector corridor intelligence

Medicaments
top trade corridors

HS4 3003 - leading exporter-to-importer routes

Explore reported routes for this HS4 subsector, ranked by latest trade value and paired with growth, market share, access, tariff, and distance context.

HS4 30031995-2024Rapid growth
The route picture at a glanceHS4 3003 - reported trade
01

Latest HS4 trade

$17.1BReported value
02

Corridors shown

25Leading routes by value
03

Leading route value

$3.6BLatest reported value
04

Leading route growth

+448.1%Calculated 3-year change
05

Latest reported year

20241995-2024 coverage

The HS4 corridor read

Ireland to Belgium leads the reported HS4 3003 routes.

The leading route recorded $3.6B in 2024, with +448.1% calculated three-year growth. Across the HS4 subsector, latest reported trade was $17.1B, with +23% calculated three-year growth. Read the HS4 overview ↗

Leading route$3.6B21.1% of latest HS4 trade

Top HS4 corridors

Where Medicaments trade moves

Observed exporter-to-importer relationships ranked by latest reported trade value. Growth, peak comparisons, and shares are calculated indicators; access fields provide context where available. Review data sources ↗

HS4 3003 exporter-to-importer relationshipsTop 25 by value

Scroll horizontally to compare all route fields.

RankExporterImporterLatest trade3-year CAGR5-year CAGR10-year CAGRMarket shareFTA / accessApplied tariffMFN tariffPreferential tariffTariff advantageDistanceHistorical peakLatest below peakYearsTrend
1IrelandIRLBelgiumBEL$3.6B+448.1%+442.6%+101.5%21.1%FTA reported0%0%0%+0 pp776 km$3.6B20240%26Rapid growth
2PortugalPRTUSA, Puerto Rico and US Virgin IslandsUSA$900.5M+126.2%+74.1%+60.1%5.3%No FTA reported0%0%Not reportedNot reported5,435 km$1.1B202319.1%24Rapid growth
3USA, Puerto Rico and US Virgin IslandsUSAGermanyDEU$864.8M+36%+21.3%+14.5%5.1%No FTA reported0.1%0.1%Not reportedNot reported6,402 km$1.1B202318.8%30Rapid growth
4PortugalPRTGermanyDEU$451.1M+174.3%+116.4%+67.9%2.6%FTA reported0%0%0%+0 pp2,316 km$451.1M20240%28Rapid growth
5Switzerland, LiechtensteinCHESpainESP$413.9M+40.3%+5.9%+59.2%2.4%FTA reported0%0.1%0%+0 pp1,245 km$437.6M20225.4%30Rapid growth
6IrelandIRLPortugalPRT$279.2M+705.1%+140.2%+49.7%1.6%FTA reported0%0%0%+0 pp1,640 km$279.2M20240%30Rapid growth
7SingaporeSGPUSA, Puerto Rico and US Virgin IslandsUSA$275.5M+3.1%+20.8%+43.8%1.6%FTA reported0%0%0%+0 pp15,347 km$490.1M201843.8%30Growing
8ItalyITAUSA, Puerto Rico and US Virgin IslandsUSA$247.6M+36.2%+41.7%+37.1%1.4%No FTA reported0%0%Not reportedNot reported6,907 km$349.6M202029.2%30Rapid growth
9USA, Puerto Rico and US Virgin IslandsUSAIrelandIRL$236.7M-23.4%-14.7%-7.1%1.4%No FTA reported0.1%0.1%Not reportedNot reported5,129 km$738.6M201768%30Rapid decline
10USA, Puerto Rico and US Virgin IslandsUSABelgiumBEL$217.1M+104.6%+114%+37.5%1.3%No FTA reported0.1%0.1%Not reportedNot reported5,904 km$217.1M20240%26Rapid growth
11PortugalPRTCanadaCAN$206.6M+146.9%+127.3%+69.4%1.2%FTA reported0.1%0.1%0%+0.1 pp5,741 km$375.0M202244.9%25Rapid growth
12ChinaCHNIndiaIND$191.8M+19.3%+15.1%+14.9%1.1%No FTA reported0.5%0.5%0.1%+0.5 pp4,252 km$191.8M20240%30Rapid growth
13BelgiumBELGermanyDEU$178.1M+175.8%+85.6%+51.3%1%FTA reported0%0%0%+0 pp653 km$250.7M202329%26Rapid growth
14ItalyITANetherlandsNLD$176.8M+174.5%+92%+38.2%1%FTA reported0%0%0%+0 pp1,298 km$176.8M20240%30Rapid growth
15IrelandIRLUSA, Puerto Rico and US Virgin IslandsUSA$165.4M+95.5%+28.2%+14.5%1%No FTA reported0%0%Not reportedNot reported5,129 km$854.6M201280.7%30Rapid growth
16SpainESPGermanyDEU$139.7M+151.6%+20%+13.7%0.8%FTA reported0%0%0%+0 pp1,872 km$217.0M202335.6%30Rapid growth
17FranceFRAJapanJPN$134.2M+363.7%+134%+41.5%0.8%FTA reported0%0%0%+0 pp9,736 km$134.2M20240%30Rapid growth
18ChinaCHNJapanJPN$132.6M+13.8%+12.2%+11.4%0.8%No FTA reported0%0%0%+0 pp1,763 km$132.6M20240%30Rapid growth
19IrelandIRLGermanyDEU$127.2M+150.1%+52.4%+20.8%0.7%FTA reported0%0%0%+0 pp1,321 km$5.3B200897.6%30Rapid growth
20ItalyITASwitzerland, LiechtensteinCHE$121.9M+7.1%+18%+11.3%0.7%FTA reported0%0%0%-0 pp684 km$196.0M202237.8%30Growing
21USA, Puerto Rico and US Virgin IslandsUSANetherlandsNLD$121.0M+66.7%+18.1%+18.2%0.7%No FTA reported0.1%0.1%Not reportedNot reported5,877 km$127.6M20085.2%30Rapid growth
22GermanyDEUIrelandIRL$118.5M+17.7%-16.7%+14.6%0.7%FTA reported0%0%0%+0 pp1,321 km$5.5B201897.8%30Rapid growth
23Switzerland, LiechtensteinCHEUSA, Puerto Rico and US Virgin IslandsUSA$112.8M+20.5%+5.4%+32.2%0.7%No FTA reported0%0%Not reportedNot reported6,339 km$122.2M20077.7%30Rapid growth
24FranceFRAChinaCHN$107.4M+43.2%+40.8%+34.9%0.6%No FTA reported0.3%0.3%Not reportedNot reported9,284 km$107.4M20240%30Rapid growth
25GermanyDEUGreeceGRC$97.2M+7.3%+28.4%+53%0.6%FTA reported0%0%0%+0 pp1,807 km$113.6M200514.5%30Growing

Movement to watch

Growth leaders for HS4 3003

The strongest available three-year growth rates are starting points for research, not forecasts. Compare the calculated rate with each route's reported value, share, and trend. Read the methodology ↗

01Growth leader

Ireland to Portugal

+705.1%calculated 3-year CAGR
$279.2M latest value1.6% market shareRapid growth
02Growth leader

Ireland to Belgium

+448.1%calculated 3-year CAGR
$3.6B latest value21.1% market shareRapid growth
03Growth leader

France to Japan

+363.7%calculated 3-year CAGR
$134.2M latest value0.8% market shareRapid growth
04Growth leader

Belgium to Germany

+175.8%calculated 3-year CAGR
$178.1M latest value1% market shareRapid growth
05Growth leader

Italy to Netherlands

+174.5%calculated 3-year CAGR
$176.8M latest value1% market shareRapid growth

Access and tariff context

Compare route access without over-reading one indicator

FTA status, applied tariffs, tariff advantage, and distance are supporting route context. Group averages are calculated from displayed routes and are not tariff recommendations. Check data coverage ↗

FTA reported$6.3B

14 displayed routes with average calculated growth of +183.2%.

Average applied tariff
0%
Average tariff advantage
+0 pp
No FTA reported$3.3B

11 displayed routes with average calculated growth of +48.9%.

Average applied tariff
0.1%
Average tariff advantage
+0.2 pp
Lowest reported applied tariffFTA reported

Ireland to Belgium

0%

Routes with an available applied tariff. Latest route value: $3.6B.

Applied 0%Advantage +0 pp776 km
Largest reported tariff advantageNo FTA reported

China to India

+0.5 pp

Routes with an available tariff advantage. Latest route value: $191.8M.

Applied 0.5%Advantage +0.5 pp4,252 km

HS4 indicators

Scale, momentum, and structure in one view

These cards pair reported trade observations with calculated indicators from the available HS4 history. See indicator definitions ↗

Displayed route value$9.6B

Combined reported value across the 25 routes shown.

HS4 3-year CAGR+23%

Calculated annualized change in reported HS4 trade.

Exporter / importer HHI3,620.8 / 3,069.7

Calculated concentration indicators; higher values mean a more concentrated mix.

Trade volatility0.4

Calculated variation in annual reported HS4 trade.

Trend and peakRapid growth

Historical peak: $17.1B in 2024. Latest below peak: 0%.

Coverage and breadth1995-2024

30 observed years; 4,176 active corridors, 156 exporters, 200 importers, and 10 HS6 products.

How to read this view

Keep reported scale separate from calculated movement.

Latest trade values describe reported merchandise trade for HS4 3003. Growth, market share, HHI, volatility, and peak comparisons are calculated indicators over the stated coverage period.

FTA status, tariffs, and distance add route context where available. A missing value stays unavailable; it is not treated as zero or a forecast.

Data source

OECD trade statistics with CEPII context

OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-28). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.